Sexually Transmitted Diseases

Information for Professionals

Alerts and Advisories

CDC announces that fluoroquinolones are no longer recommended for the treatment of gonorrhea in the United States.

MMWR: Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections. April 13, 2007 / 56(14);332-336

Update on the Management of Gonorrhea in Adults
in the United States

Lymphogranuloma Venereum (LGV) Presenting As Inflammatory Bowel Disease Or Proctitis February 25, 2005

Centers for Disease Control and Prevention Lymphogranuloma Venereum (LGV) Surveillance Project
To evaluate LGV infection in the U.S., the Centers for Disease Control and Prevention’s (CDC), Division of STD Prevention (DSTDP) is tracking the number of cases of LGV. We are asking clinicians of patients with clinical symptoms consistent with LGV to report these cases to their local health departments and to CDC. Symptoms of LGV include: mucous or purulent anal discharge, rectal bleeding, constipation, inguinal/femoral lymphadenopathy (buboes), genital or rectal ulcer or papule, anal spasms, and tenesmus.

Two New York City Residents Diagnosed with Rare Sexually Transmitted Infection; Same Strain Found in Europe 2/2/05